Smoking Cessation App for Mental Illness

Recruiting in Palo Alto (17 mi)

Overseen byGail Daumit

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Johns Hopkins University

No Placebo Group

Trial Summary

What is the purpose of this trial?

This is a pilot randomized clinical trial testing an implementation intervention to support delivery of a smoking cessation app tailored to the needs of those individuals with SMI who at community mental health programs.

Research Team

Gail Daumit

Principal Investigator

Johns Hopkins University

Eligibility Criteria

This trial is for regular smokers with serious mental illness (SMI) who are part of the Johns Hopkins Bayview Adult Psychiatry Program and own a smartphone. They must be willing to quit smoking. Pregnant women or those planning to become pregnant within 3 months cannot participate.

Inclusion Criteria

I am a smoker but willing to quit.

I am willing to participate in the trial.

Must be a mental health consumer at Johns Hopkins Bayview Adult Psychiatry Program

See 1 more

Exclusion Criteria

I am not pregnant and do not plan to become pregnant in the next 3 months.

Treatment Details

Interventions

LTQ (Behavioural Intervention)

Trial OverviewThe study is testing a new smoking cessation app designed specifically for individuals with SMI. Participants will use this digital therapeutic tool remotely, and its effectiveness in helping them quit smoking will be evaluated.

Participant Groups

1Treatment groups

Experimental Treatment

Group I: Consumers who smoke at outpatient community mental health clinicExperimental Treatment1 Intervention

Consumers with serious mental illness who attend outpatient community mental health clinic will participate in a smoking cessation with the LTQ application and nicotine replacement therapy